This includes medications like Wegovy and Zepbound, which are specifically indicated for weight loss
Clinical studies have demonstrated that patients can lose more than 50 pounds within six months, even without altering their existing diet or exercise habits
Most significant results appear between months 6-12 with consistent use
May your dose schedule stay consistent, your titration stay smooth, and your results stay on track.
Plus, it mimics the other effects of GLP-1 that lead to decreased appetite and subsequent reduced energy intake and weight loss
GLP-1 and GIP-based therapies may be appropriate for individuals with Type 2 diabetes, insulin resistance, or those who are overweight (BMI 2730+) with at least one weight-related condition such as high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease